CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019 Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain Successful catheter ablation of electrical storm after myocardial infarction Natural History of Spontaneous Coronary Artery Dissection With Spontaneous Angiographic Healing Cardiac monocytes and macrophages after myocardial infarction Predicting Major Adverse Events in Patients With Acute Myocardial Infarction An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Cardiac Troponin Elevation in Patients Without a Specific Diagnosis Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With STEMI: A Cardiac Magnetic Resonance Study Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I

Clinical Trial14 Oct 2020

JOURNAL:Circulation. Article Link

Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial

GJ Vlachojannis , JM Wilschut , RF Vogel et al. Keywords: pre-hospital crushed prasugrel tablet vs. integral prasugrel tablet; oral platelet P2Y12 inhibiton

Full Text PDF